Relative Strength Chart Can-Fite BioPharma Ltd.

Equities

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:53 2025-07-09 am EDT			5-day change	1st Jan Change
1.200 ^ILa	-7.69%		0.00%	-36.84%

Jun. 16	Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston	CI
May. 05	Can-Fite Says It Has Raised $175 Million To Date For Development Of Namodenoson And Piclidenoson	RE

End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	CAN-FITE BIOPHARMA LTD.	Biopharmaceuticals	-7.69%	0.00%	-36.84%	-64.71%	-94.31%	15.43M